RNA-Targeted Small Molecule Drugs Market, Global Outlook and Forecast 2022-2028

August 2022 | 106 pages | ID: R78F1BE9E7DCEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of RNA-Targeted Small Molecule Drugs in Global, including the following market information:

Global RNA-Targeted Small Molecule Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global RNA-Targeted Small Molecule Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

mRNA Translation Regulation Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of RNA-Targeted Small Molecule Drugs include Roche, Novartis, PTC Therapeutics, Biogen, Accent Therapeutics, Anima Biotech, Arrakis Pharmaceuticals, Epics Therapeutics and Expansion Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the RNA-Targeted Small Molecule Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global RNA-Targeted Small Molecule Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global RNA-Targeted Small Molecule Drugs Market Segment Percentages, by Type, 2021 (%)

• mRNA Translation Regulation
• RNA Splicing Modification
• Direct RNA Targeting
• Indirect RNA Targeting - Epitranscriptomics

Global RNA-Targeted Small Molecule Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global RNA-Targeted Small Molecule Drugs Market Segment Percentages, by Application, 2021 (%)

• SMA
• Oncology
• Lung Fibrosis
• Huntington's Disease
• Others

Global RNA-Targeted Small Molecule Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global RNA-Targeted Small Molecule Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies RNA-Targeted Small Molecule Drugs revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies RNA-Targeted Small Molecule Drugs revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Roche
• Novartis
• PTC Therapeutics
• Biogen
• Accent Therapeutics
• Anima Biotech
• Arrakis Pharmaceuticals
• Epics Therapeutics
• Expansion Therapeutics
• Gotham Therapeutics
• H3 Biomedicine
• Ribometrix
• Skyhawk Therapeutics
• STORM Therapeutics
• Twentyeight-Seven Therapeutics

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 RNA-Targeted Small Molecule Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global RNA-Targeted Small Molecule Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL RNA-TARGETED SMALL MOLECULE DRUGS OVERALL MARKET SIZE

2.1 Global RNA-Targeted Small Molecule Drugs Market Size: 2021 VS 2028
2.2 Global RNA-Targeted Small Molecule Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top RNA-Targeted Small Molecule Drugs Players in Global Market
3.2 Top Global RNA-Targeted Small Molecule Drugs Companies Ranked by Revenue
3.3 Global RNA-Targeted Small Molecule Drugs Revenue by Companies
3.4 Top 3 and Top 5 RNA-Targeted Small Molecule Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies RNA-Targeted Small Molecule Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 RNA-Targeted Small Molecule Drugs Players in Global Market
  3.6.1 List of Global Tier 1 RNA-Targeted Small Molecule Drugs Companies
  3.6.2 List of Global Tier 2 and Tier 3 RNA-Targeted Small Molecule Drugs Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global RNA-Targeted Small Molecule Drugs Market Size Markets, 2021 & 2028
  4.1.2 mRNA Translation Regulation
  4.1.3 RNA Splicing Modification
  4.1.4 Direct RNA Targeting
  4.1.5 Indirect RNA Targeting - Epitranscriptomics
4.2 By Type - Global RNA-Targeted Small Molecule Drugs Revenue & Forecasts
  4.2.1 By Type - Global RNA-Targeted Small Molecule Drugs Revenue, 2017-2022
  4.2.2 By Type - Global RNA-Targeted Small Molecule Drugs Revenue, 2023-2028
  4.2.3 By Type - Global RNA-Targeted Small Molecule Drugs Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global RNA-Targeted Small Molecule Drugs Market Size, 2021 & 2028
  5.1.2 SMA
  5.1.3 Oncology
  5.1.4 Lung Fibrosis
  5.1.5 Huntington's Disease
  5.1.6 Others
5.2 By Application - Global RNA-Targeted Small Molecule Drugs Revenue & Forecasts
  5.2.1 By Application - Global RNA-Targeted Small Molecule Drugs Revenue, 2017-2022
  5.2.2 By Application - Global RNA-Targeted Small Molecule Drugs Revenue, 2023-2028
  5.2.3 By Application - Global RNA-Targeted Small Molecule Drugs Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global RNA-Targeted Small Molecule Drugs Market Size, 2021 & 2028
6.2 By Region - Global RNA-Targeted Small Molecule Drugs Revenue & Forecasts
  6.2.1 By Region - Global RNA-Targeted Small Molecule Drugs Revenue, 2017-2022
  6.2.2 By Region - Global RNA-Targeted Small Molecule Drugs Revenue, 2023-2028
  6.2.3 By Region - Global RNA-Targeted Small Molecule Drugs Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America RNA-Targeted Small Molecule Drugs Revenue, 2017-2028
  6.3.2 US RNA-Targeted Small Molecule Drugs Market Size, 2017-2028
  6.3.3 Canada RNA-Targeted Small Molecule Drugs Market Size, 2017-2028
  6.3.4 Mexico RNA-Targeted Small Molecule Drugs Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe RNA-Targeted Small Molecule Drugs Revenue, 2017-2028
  6.4.2 Germany RNA-Targeted Small Molecule Drugs Market Size, 2017-2028
  6.4.3 France RNA-Targeted Small Molecule Drugs Market Size, 2017-2028
  6.4.4 U.K. RNA-Targeted Small Molecule Drugs Market Size, 2017-2028
  6.4.5 Italy RNA-Targeted Small Molecule Drugs Market Size, 2017-2028
  6.4.6 Russia RNA-Targeted Small Molecule Drugs Market Size, 2017-2028
  6.4.7 Nordic Countries RNA-Targeted Small Molecule Drugs Market Size, 2017-2028
  6.4.8 Benelux RNA-Targeted Small Molecule Drugs Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia RNA-Targeted Small Molecule Drugs Revenue, 2017-2028
  6.5.2 China RNA-Targeted Small Molecule Drugs Market Size, 2017-2028
  6.5.3 Japan RNA-Targeted Small Molecule Drugs Market Size, 2017-2028
  6.5.4 South Korea RNA-Targeted Small Molecule Drugs Market Size, 2017-2028
  6.5.5 Southeast Asia RNA-Targeted Small Molecule Drugs Market Size, 2017-2028
  6.5.6 India RNA-Targeted Small Molecule Drugs Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America RNA-Targeted Small Molecule Drugs Revenue, 2017-2028
  6.6.2 Brazil RNA-Targeted Small Molecule Drugs Market Size, 2017-2028
  6.6.3 Argentina RNA-Targeted Small Molecule Drugs Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa RNA-Targeted Small Molecule Drugs Revenue, 2017-2028
  6.7.2 Turkey RNA-Targeted Small Molecule Drugs Market Size, 2017-2028
  6.7.3 Israel RNA-Targeted Small Molecule Drugs Market Size, 2017-2028
  6.7.4 Saudi Arabia RNA-Targeted Small Molecule Drugs Market Size, 2017-2028
  6.7.5 UAE RNA-Targeted Small Molecule Drugs Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Roche
  7.1.1 Roche Corporate Summary
  7.1.2 Roche Business Overview
  7.1.3 Roche RNA-Targeted Small Molecule Drugs Major Product Offerings
  7.1.4 Roche RNA-Targeted Small Molecule Drugs Revenue in Global Market (2017-2022)
  7.1.5 Roche Key News
7.2 Novartis
  7.2.1 Novartis Corporate Summary
  7.2.2 Novartis Business Overview
  7.2.3 Novartis RNA-Targeted Small Molecule Drugs Major Product Offerings
  7.2.4 Novartis RNA-Targeted Small Molecule Drugs Revenue in Global Market (2017-2022)
  7.2.5 Novartis Key News
7.3 PTC Therapeutics
  7.3.1 PTC Therapeutics Corporate Summary
  7.3.2 PTC Therapeutics Business Overview
  7.3.3 PTC Therapeutics RNA-Targeted Small Molecule Drugs Major Product Offerings
  7.3.4 PTC Therapeutics RNA-Targeted Small Molecule Drugs Revenue in Global Market (2017-2022)
  7.3.5 PTC Therapeutics Key News
7.4 Biogen
  7.4.1 Biogen Corporate Summary
  7.4.2 Biogen Business Overview
  7.4.3 Biogen RNA-Targeted Small Molecule Drugs Major Product Offerings
  7.4.4 Biogen RNA-Targeted Small Molecule Drugs Revenue in Global Market (2017-2022)
  7.4.5 Biogen Key News
7.5 Accent Therapeutics
  7.5.1 Accent Therapeutics Corporate Summary
  7.5.2 Accent Therapeutics Business Overview
  7.5.3 Accent Therapeutics RNA-Targeted Small Molecule Drugs Major Product Offerings
  7.5.4 Accent Therapeutics RNA-Targeted Small Molecule Drugs Revenue in Global Market (2017-2022)
  7.5.5 Accent Therapeutics Key News
7.6 Anima Biotech
  7.6.1 Anima Biotech Corporate Summary
  7.6.2 Anima Biotech Business Overview
  7.6.3 Anima Biotech RNA-Targeted Small Molecule Drugs Major Product Offerings
  7.6.4 Anima Biotech RNA-Targeted Small Molecule Drugs Revenue in Global Market (2017-2022)
  7.6.5 Anima Biotech Key News
7.7 Arrakis Pharmaceuticals
  7.7.1 Arrakis Pharmaceuticals Corporate Summary
  7.7.2 Arrakis Pharmaceuticals Business Overview
  7.7.3 Arrakis Pharmaceuticals RNA-Targeted Small Molecule Drugs Major Product Offerings
  7.7.4 Arrakis Pharmaceuticals RNA-Targeted Small Molecule Drugs Revenue in Global Market (2017-2022)
  7.7.5 Arrakis Pharmaceuticals Key News
7.8 Epics Therapeutics
  7.8.1 Epics Therapeutics Corporate Summary
  7.8.2 Epics Therapeutics Business Overview
  7.8.3 Epics Therapeutics RNA-Targeted Small Molecule Drugs Major Product Offerings
  7.8.4 Epics Therapeutics RNA-Targeted Small Molecule Drugs Revenue in Global Market (2017-2022)
  7.8.5 Epics Therapeutics Key News
7.9 Expansion Therapeutics
  7.9.1 Expansion Therapeutics Corporate Summary
  7.9.2 Expansion Therapeutics Business Overview
  7.9.3 Expansion Therapeutics RNA-Targeted Small Molecule Drugs Major Product Offerings
  7.9.4 Expansion Therapeutics RNA-Targeted Small Molecule Drugs Revenue in Global Market (2017-2022)
  7.9.5 Expansion Therapeutics Key News
7.10 Gotham Therapeutics
  7.10.1 Gotham Therapeutics Corporate Summary
  7.10.2 Gotham Therapeutics Business Overview
  7.10.3 Gotham Therapeutics RNA-Targeted Small Molecule Drugs Major Product Offerings
  7.10.4 Gotham Therapeutics RNA-Targeted Small Molecule Drugs Revenue in Global Market (2017-2022)
  7.10.5 Gotham Therapeutics Key News
7.11 H3 Biomedicine
  7.11.1 H3 Biomedicine Corporate Summary
  7.11.2 H3 Biomedicine Business Overview
  7.11.3 H3 Biomedicine RNA-Targeted Small Molecule Drugs Major Product Offerings
  7.11.4 H3 Biomedicine RNA-Targeted Small Molecule Drugs Revenue in Global Market (2017-2022)
  7.11.5 H3 Biomedicine Key News
7.12 Ribometrix
  7.12.1 Ribometrix Corporate Summary
  7.12.2 Ribometrix Business Overview
  7.12.3 Ribometrix RNA-Targeted Small Molecule Drugs Major Product Offerings
  7.12.4 Ribometrix RNA-Targeted Small Molecule Drugs Revenue in Global Market (2017-2022)
  7.12.5 Ribometrix Key News
7.13 Skyhawk Therapeutics
  7.13.1 Skyhawk Therapeutics Corporate Summary
  7.13.2 Skyhawk Therapeutics Business Overview
  7.13.3 Skyhawk Therapeutics RNA-Targeted Small Molecule Drugs Major Product Offerings
  7.13.4 Skyhawk Therapeutics RNA-Targeted Small Molecule Drugs Revenue in Global Market (2017-2022)
  7.13.5 Skyhawk Therapeutics Key News
7.14 STORM Therapeutics
  7.14.1 STORM Therapeutics Corporate Summary
  7.14.2 STORM Therapeutics Business Overview
  7.14.3 STORM Therapeutics RNA-Targeted Small Molecule Drugs Major Product Offerings
  7.14.4 STORM Therapeutics RNA-Targeted Small Molecule Drugs Revenue in Global Market (2017-2022)
  7.14.5 STORM Therapeutics Key News
7.15 Twentyeight-Seven Therapeutics
  7.15.1 Twentyeight-Seven Therapeutics Corporate Summary
  7.15.2 Twentyeight-Seven Therapeutics Business Overview
  7.15.3 Twentyeight-Seven Therapeutics RNA-Targeted Small Molecule Drugs Major Product Offerings
  7.15.4 Twentyeight-Seven Therapeutics RNA-Targeted Small Molecule Drugs Revenue in Global Market (2017-2022)
  7.15.5 Twentyeight-Seven Therapeutics Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. RNA-Targeted Small Molecule Drugs Market Opportunities & Trends in Global Market
Table 2. RNA-Targeted Small Molecule Drugs Market Drivers in Global Market
Table 3. RNA-Targeted Small Molecule Drugs Market Restraints in Global Market
Table 4. Key Players of RNA-Targeted Small Molecule Drugs in Global Market
Table 5. Top RNA-Targeted Small Molecule Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global RNA-Targeted Small Molecule Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global RNA-Targeted Small Molecule Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies RNA-Targeted Small Molecule Drugs Product Type
Table 9. List of Global Tier 1 RNA-Targeted Small Molecule Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 RNA-Targeted Small Molecule Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - RNA-Targeted Small Molecule Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - RNA-Targeted Small Molecule Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - RNA-Targeted Small Molecule Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - RNA-Targeted Small Molecule Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global RNA-Targeted Small Molecule Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global RNA-Targeted Small Molecule Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Roche Corporate Summary
Table 31. Roche RNA-Targeted Small Molecule Drugs Product Offerings
Table 32. Roche RNA-Targeted Small Molecule Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Novartis Corporate Summary
Table 34. Novartis RNA-Targeted Small Molecule Drugs Product Offerings
Table 35. Novartis RNA-Targeted Small Molecule Drugs Revenue (US$, Mn), (2017-2022)
Table 36. PTC Therapeutics Corporate Summary
Table 37. PTC Therapeutics RNA-Targeted Small Molecule Drugs Product Offerings
Table 38. PTC Therapeutics RNA-Targeted Small Molecule Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Biogen Corporate Summary
Table 40. Biogen RNA-Targeted Small Molecule Drugs Product Offerings
Table 41. Biogen RNA-Targeted Small Molecule Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Accent Therapeutics Corporate Summary
Table 43. Accent Therapeutics RNA-Targeted Small Molecule Drugs Product Offerings
Table 44. Accent Therapeutics RNA-Targeted Small Molecule Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Anima Biotech Corporate Summary
Table 46. Anima Biotech RNA-Targeted Small Molecule Drugs Product Offerings
Table 47. Anima Biotech RNA-Targeted Small Molecule Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Arrakis Pharmaceuticals Corporate Summary
Table 49. Arrakis Pharmaceuticals RNA-Targeted Small Molecule Drugs Product Offerings
Table 50. Arrakis Pharmaceuticals RNA-Targeted Small Molecule Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Epics Therapeutics Corporate Summary
Table 52. Epics Therapeutics RNA-Targeted Small Molecule Drugs Product Offerings
Table 53. Epics Therapeutics RNA-Targeted Small Molecule Drugs Revenue (US$, Mn), (2017-2022)
Table 54. Expansion Therapeutics Corporate Summary
Table 55. Expansion Therapeutics RNA-Targeted Small Molecule Drugs Product Offerings
Table 56. Expansion Therapeutics RNA-Targeted Small Molecule Drugs Revenue (US$, Mn), (2017-2022)
Table 57. Gotham Therapeutics Corporate Summary
Table 58. Gotham Therapeutics RNA-Targeted Small Molecule Drugs Product Offerings
Table 59. Gotham Therapeutics RNA-Targeted Small Molecule Drugs Revenue (US$, Mn), (2017-2022)
Table 60. H3 Biomedicine Corporate Summary
Table 61. H3 Biomedicine RNA-Targeted Small Molecule Drugs Product Offerings
Table 62. H3 Biomedicine RNA-Targeted Small Molecule Drugs Revenue (US$, Mn), (2017-2022)
Table 63. Ribometrix Corporate Summary
Table 64. Ribometrix RNA-Targeted Small Molecule Drugs Product Offerings
Table 65. Ribometrix RNA-Targeted Small Molecule Drugs Revenue (US$, Mn), (2017-2022)
Table 66. Skyhawk Therapeutics Corporate Summary
Table 67. Skyhawk Therapeutics RNA-Targeted Small Molecule Drugs Product Offerings
Table 68. Skyhawk Therapeutics RNA-Targeted Small Molecule Drugs Revenue (US$, Mn), (2017-2022)
Table 69. STORM Therapeutics Corporate Summary
Table 70. STORM Therapeutics RNA-Targeted Small Molecule Drugs Product Offerings
Table 71. STORM Therapeutics RNA-Targeted Small Molecule Drugs Revenue (US$, Mn), (2017-2022)
Table 72. Twentyeight-Seven Therapeutics Corporate Summary
Table 73. Twentyeight-Seven Therapeutics RNA-Targeted Small Molecule Drugs Product Offerings
Table 74. Twentyeight-Seven Therapeutics RNA-Targeted Small Molecule Drugs Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. RNA-Targeted Small Molecule Drugs Segment by Type in 2021
Figure 2. RNA-Targeted Small Molecule Drugs Segment by Application in 2021
Figure 3. Global RNA-Targeted Small Molecule Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global RNA-Targeted Small Molecule Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global RNA-Targeted Small Molecule Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by RNA-Targeted Small Molecule Drugs Revenue in 2021
Figure 8. By Type - Global RNA-Targeted Small Molecule Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global RNA-Targeted Small Molecule Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global RNA-Targeted Small Molecule Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America RNA-Targeted Small Molecule Drugs Revenue Market Share, 2017-2028
Figure 12. US RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe RNA-Targeted Small Molecule Drugs Revenue Market Share, 2017-2028
Figure 16. Germany RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia RNA-Targeted Small Molecule Drugs Revenue Market Share, 2017-2028
Figure 24. China RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America RNA-Targeted Small Molecule Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa RNA-Targeted Small Molecule Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Roche RNA-Targeted Small Molecule Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novartis RNA-Targeted Small Molecule Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. PTC Therapeutics RNA-Targeted Small Molecule Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Biogen RNA-Targeted Small Molecule Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Accent Therapeutics RNA-Targeted Small Molecule Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Anima Biotech RNA-Targeted Small Molecule Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Arrakis Pharmaceuticals RNA-Targeted Small Molecule Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Epics Therapeutics RNA-Targeted Small Molecule Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Expansion Therapeutics RNA-Targeted Small Molecule Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Gotham Therapeutics RNA-Targeted Small Molecule Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. H3 Biomedicine RNA-Targeted Small Molecule Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Ribometrix RNA-Targeted Small Molecule Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Skyhawk Therapeutics RNA-Targeted Small Molecule Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. STORM Therapeutics RNA-Targeted Small Molecule Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Twentyeight-Seven Therapeutics RNA-Targeted Small Molecule Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)